BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11136321)

  • 1. High-risk colorectal adenomas and serum insulin-like growth factors.
    Renehan AG; Painter JE; Atkin WS; Potten CS; Shalet SM; O'Dwyer ST
    Br J Surg; 2001 Jan; 88(1):107-13. PubMed ID: 11136321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
    Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
    Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis.
    Jacobs ET; Martínez ME; Alberts DS; Ashbeck EL; Gapstur SM; Lance P; Thompson PA
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):300-5. PubMed ID: 18250342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
    Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
    Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST
    Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
    Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating insulin-like growth factor II and colorectal adenomas.
    Renehan AG; Painter JE; O'Halloran D; Atkin WS; Potten CS; O'Dwyer ST; Shalet SM
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3402-8. PubMed ID: 10999841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
    Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer.
    Vrieling A; Rookus MA; Kampman E; Bonfrer JM; Bosma A; Cats A; van Doorn J; Korse CM; Witteman BJ; van Leeuwen FE; van't Veer LJ; Voskuil DW
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2585-93. PubMed ID: 18842999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
    Rinaldi S; Kaaks R; Zeleniuch-Jacquotte A; Arslan AA; Shore RE; Koenig KL; Dossus L; Riboli E; Stattin P; Lukanova A; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, apoptosis, and colorectal adenoma risk.
    Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
    Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
    Vatten LJ; Holly JM; Gunnell D; Tretli S
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3.
    Flood A; Mai V; Pfeiffer R; Kahle L; Remaley AT; Rosen CJ; Lanza E; Schatzkin A
    Eur J Clin Nutr; 2008 Feb; 62(2):186-96. PubMed ID: 17487212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.